Ireland - Financial Media Contact
Powerscourt
Tel: +353 (0)1 536 0682
2023 Annual Report
RNS Announcements
Investee Companies
Wed, 28 Feb 2024
2023 Full Year Results and Notice of 2024 AGM
Thu, 22 Feb 2024
Notice of Full Year 2023 Results
Fri, 26 Jan 2024
Holding(s) in Company
Thu, 25 Jan 2024
CG Oncology Announces Pricing of Upsized IPO
Wed, 20 Dec 2023
Director/PDMR Shareholding
News Archive>
13 Mar 2024
Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma
07 Mar 2024
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023
28 Feb 2024
CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancer
30 Jan 2024
CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
11 Dec 2023
Poseida Therapeutics Presents Positive Early Results from its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting